Turkish Chronic Total Occlusion Percutaneous Coronary Intervention Registry

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAhmet Seyfeddin Gürbüz

About this trial

The TURK CTO Registry is a prospective, multicenter, observational registry designed to evaluate the contemporary management and outcomes of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) in Türkiye.

The registry will include consecutive adult patients undergoing CTO PCI at participating centers. Detailed data on patient characteristics, cardiovascular risk factors, lesion and procedural characteristics, CTO crossing strategies, guidewires and devices, procedural techniques, radiation exposure, contrast use, procedural success, and in-hospital complications will be collected using a standardized electronic data collection system.

The primary objective of the registry is to characterize contemporary CTO PCI practice in Türkiye and to evaluate procedural success and safety. Secondary objectives include identifying clinical, angiographic, and procedural factors associated with technical and procedural success, complications, resource utilization, and patient outcomes.

The registry is expected to provide real-world, multicenter data on CTO PCI practice and to help identify factors associated with successful and safe CTO revascularization in Türkiye. No treatment or procedural strategy will be assigned by the study protocol; all clinical and procedural decisions will be made by the treating physicians according to routine clinical practice.

Eligibility criteria

Qualifiers

Age ≥18 years

Presence of at least one coronary chronic total occlusion (CTO), defined as a coronary artery lesion with TIMI grade 0 antegrade flow and an estimated duration of occlusion of ≥3 months

Undergoing an attempted PCI of the CTO at a participating center during the study period

Provision of informed consent when required by the applicable ethics committee and local regulations

Disqualifiers

Age <18 years

Coronary lesion not meeting the predefined criteria for CTO

No attempted CTO PCI during the procedure

Inability or refusal to provide informed consent when informed consent is required

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

70,000 Participants
are grouped into 1 trial group

Sponsors and collaborators

Ahmet Seyfeddin Gürbüz

Lead sponsor

Necmettin Erbakan University

Sponsor institution